O6.01 TARGETING THE IMMUNE CHECKPOINT NETWORK WITH MIR-138 EXERTS THERAPEUTIC EFFICACY IN MURINE MODELS OF GLIOMA

Antibody therapeutic targeting of the immune checkpoints CTLA-4 and PD-1 has demonstrated marked tumor regression in clinical trials; however, this requires multimodality treatment and has known toxicity. Furthermore, the targeting of one checkpoint often results in the up-regulation of another. Mic...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Heimberger, A., Wei, J., Nduom, E., Kong, L., Ivan, C., Fuller, G.N., Gilbert, M.R., Conrad, C.A., Calin, G.A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2014
Aiheet:
Oral Presentations
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4185794/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou174.42
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia